Novartis AG Goodwill
Novartis AG (NVSEF) had Goodwill of $25.57 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Intangible Assets
ifrs-full:Goodwill · last filed 2026-02-04
- 2025-12-31: Goodwill $25.57B.
- 2025-06-30: Goodwill $25.55B.
- 2024-12-31: Goodwill $24.76B.
- 2024-06-30: Goodwill $25.23B.
| Period end | Goodwill |
|---|---|
| 2025-12-31 | $25.57B 20-F · filed 2026-02-04 |
| 2025-06-30 | $25.55B 6-K · filed 2025-07-17 |
| 2024-12-31 | $24.76B 20-F · filed 2026-02-04 |
| 2024-06-30 | $25.23B 6-K · filed 2024-07-18 |
| 2023-12-31 | $23.34B 20-F · filed 2025-01-31 |
| 2023-06-30 | $29.52B 6-K · filed 2023-07-18 |
| 2022-12-31 | $29.30B 20-F · filed 2024-01-31 |
| 2022-06-30 | $29.11B 6-K · filed 2022-07-19 |
| 2021-12-31 | $29.59B 20-F/A · filed 2023-05-15 |
| 2021-06-30 | $29.77B 6-K · filed 2021-07-21 |
| 2020-12-31 | $30.00B 20-F · filed 2022-02-02 |
| 2020-06-30 | $29.10B 6-K · filed 2020-07-21 |
| 2019-12-31 | $26.52B 20-F · filed 2021-01-26 |
| 2019-06-30 | $26.53B 6-K · filed 2019-07-18 |
| 2018-12-31 | $35.29B 20-F · filed 2020-01-29 |
| 2018-06-30 | $35.17B 6-K · filed 2018-07-18 |
| 2017-12-31 | $31.75B 20-F · filed 2019-01-30 |
| 2016-12-31 | $30.98B 6-K · filed 2018-01-24 |